MedPage Today on MSN5d
Novel Berberine Drug Cut HbA1c in Type 2 DiabetesMore participants in the higher-dose group than placebo achieved an HbA1c under 7% (55.9% vs 15.2%) or under 6.5% (29.4% vs 6 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback